Inflammation and Repair

On this page

🔥 The Inflammatory Arsenal: Your Body's Emergency Response System

Every cut, infection, and injury triggers an ancient defense system that can save your life or, when dysregulated, destroy tissue and drive chronic disease. You'll master how your body deploys chemical signals to dilate vessels, recruit immune cells through precise adhesion cascades, eliminate threats, and orchestrate repair-or fail to resolve, creating pathology. This lesson builds your clinical eye for recognizing inflammatory patterns, from the molecular mediators commanding each phase to the vascular and cellular choreography that determines whether healing succeeds or inflammation becomes the enemy itself.

The inflammatory response represents one of medicine's most fundamental processes, governing everything from wound healing timelines to autoimmune disease progression. Master these mechanisms, and you possess the framework for understanding pathology across every organ system.

📌 Remember: SHARP defines inflammation's cardinal signs - Swelling, Heat, Ache (dolor), Redness, Power loss (functio laesa). Each sign reflects specific vascular and cellular events with measurable parameters.

The Inflammatory Response Hierarchy

  • Immediate Response (0-30 minutes)

    • Vasoactive mediator release: histamine peaks at 5-10 minutes
    • Vascular permeability increases 3-5 fold within 15 minutes
    • Complement activation: C3a/C5a levels rise 200-400%
      • Classical pathway: antibody-mediated, 1-2 minutes
      • Alternative pathway: direct activation, 30 seconds
      • Lectin pathway: mannose-binding, 2-5 minutes
  • Early Cellular Phase (30 minutes-6 hours)

    • Neutrophil recruitment: peak at 2-4 hours
    • Selectin-mediated rolling: velocity drops from 1000 to 5 μm/sec
    • Integrin activation: firm adhesion within 30-60 seconds
      • P-selectin expression: increases 10-fold in 5 minutes
      • ICAM-1 upregulation: peaks at 4-6 hours
  • Late Cellular Phase (6-48 hours)

    • Monocyte infiltration: peaks at 24-48 hours
    • Lymphocyte recruitment: begins at 12-24 hours
    • Resolution mediator production: lipoxins peak at 24 hours
Mediator ClassPeak TimeDurationPrimary EffectClinical Marker
Histamine5-10 min30-60 minVasodilation, permeabilityImmediate wheal response
Prostaglandins15-30 min2-6 hoursPain, fever, vasodilationPGE2 >200 pg/mL
Leukotrienes30-60 min4-12 hoursBronchoconstriction, chemotaxisLTC4 >50 pg/mL
Cytokines1-4 hours12-72 hoursSystemic effects, cell activationIL-1β >10 pg/mL
Complement2-5 min30-120 minMembrane attack, chemotaxisC3a >200 ng/mL

💡 Master This: Inflammation timing predicts therapeutic windows - anti-histamines work best within 30 minutes, NSAIDs most effective at 1-4 hours, and corticosteroids optimal after 6-12 hours when transcriptional effects dominate.

The precision of inflammatory timing enables targeted therapeutic interventions that maximize efficacy while minimizing adverse effects, setting the foundation for understanding how cellular recruitment orchestrates tissue defense.


🔥 The Inflammatory Arsenal: Your Body's Emergency Response System

⚡ Cellular Command Center: The Inflammatory Cell Brigade

The Cellular Response Architecture

Loading diagram…
  • Neutrophils: The First Responders (Peak: 2-6 hours)

    • Lifespan: 6-12 hours in tissues
    • Recruitment rate: 10^9 cells/hour during acute inflammation
    • Killing mechanisms: 4 primary pathways
      • Phagocytosis: engulfs 5-20 bacteria per cell
      • Degranulation: releases 300+ antimicrobial proteins
      • NET formation: extracellular DNA traps, 15-30 minutes
      • Respiratory burst: superoxide production increases 100-fold
  • Macrophages: The Tissue Guardians (Peak: 24-72 hours)

    • Lifespan: weeks to months in tissues
    • Phenotype switching: M1 (pro-inflammatory) to M2 (repair)
    • Phagocytic capacity: 100+ apoptotic cells per macrophage
      • M1 markers: iNOS, TNF-α, IL-1β production
      • M2 markers: Arginase-1, IL-10, TGF-β secretion
      • Phenotype transition: occurs at 48-72 hours

📌 Remember: NETS describes neutrophil extracellular traps - Neutrophil Extracellular Traps Snare pathogens using DNA, histones, and antimicrobial proteins. Formation requires 15-30 minutes and indicates severe inflammatory activation.

Cell TypePeak RecruitmentLifespanPrimary FunctionFailure Consequence
Neutrophils2-6 hours6-12 hoursBacterial killing, NET formationAbscess formation, sepsis
Macrophages24-72 hoursWeeks-monthsPhagocytosis, tissue repairChronic inflammation, fibrosis
Eosinophils48-96 hours8-12 daysParasite defense, allergyTissue damage, asthma
Lymphocytes3-7 daysYearsAdaptive immunity, memoryAutoimmunity, immunodeficiency
Mast CellsResidentMonthsImmediate hypersensitivityAnaphylaxis, chronic urticaria
  • Granule proteins: 4 major cytotoxic proteins
  • Degranulation triggers: IL-5 >50 pg/mL, eotaxin >100 pg/mL
  • Tissue damage potential: major basic protein causes epithelial destruction
    • Normal blood count: <350 cells/μL
    • Mild eosinophilia: 350-1,500 cells/μL
    • Severe eosinophilia: >5,000 cells/μL (tissue damage risk)

⭐ Clinical Pearl: Eosinophil count >1,500 cells/μL with tissue infiltration indicates hypereosinophilic syndrome with organ damage risk >80%. Cardiac involvement occurs in 60% of cases with endomyocardial fibrosis.

💡 Master This: Neutrophil predominance >80% suggests bacterial infection, while lymphocyte predominance >60% indicates viral or chronic inflammation. Eosinophil predominance >20% points to parasitic, allergic, or drug-induced inflammation.

Understanding cellular recruitment patterns enables precise diagnostic discrimination and therapeutic timing, connecting to how these cells orchestrate the complex molecular mediator networks that amplify or resolve inflammatory responses.


⚡ Cellular Command Center: The Inflammatory Cell Brigade

🎯 Molecular Mediator Networks: The Chemical Command System

The Mediator Response Hierarchy

  • Immediate Mediators (Seconds to Minutes)
    • Histamine: mast cell degranulation within 30 seconds

      • H1 receptors: vasodilation, increased permeability
      • H2 receptors: gastric acid secretion, cardiac effects
      • Peak plasma levels: 5-10 minutes, returns to baseline by 60 minutes
      • Therapeutic window: antihistamines most effective <30 minutes
    • Complement Components: activation within 1-5 minutes

      • C3a/C5a: anaphylatoxins, mast cell degranulation
      • C5a: neutrophil chemotaxis, 100-fold more potent than C3a
      • MAC (C5b-9): membrane attack complex, cell lysis
      • Normal C3 levels: 90-180 mg/dL, consumption drops >50% in active inflammation
Loading diagram…
  • Early Mediators (Minutes to Hours)
    • Arachidonic Acid Metabolites: peak production 15-60 minutes
      • COX pathway: prostaglandins, thromboxanes
      • LOX pathway: leukotrienes, lipoxins
      • PGE2: vasodilation, pain, fever >38.5°C
      • LTC4/LTD4: bronchoconstriction, 1000x more potent than histamine

📌 Remember: PILL describes prostaglandin effects - Pain sensitization, Inflammation amplification, Lower platelet aggregation (PGI2), Lower gastric protection (PGE2 inhibition causes ulcers).

MediatorPeak TimeHalf-LifePrimary EffectTherapeutic Target
Histamine30 seconds2-3 minutesImmediate vasodilationH1/H2 antagonists
PGE215-30 min5-10 minutesPain, fever, vasodilationCOX inhibitors
LTC430-60 min10-30 minutesBronchoconstrictionLeukotriene antagonists
TNF-α1-4 hours20-30 minutesSystemic inflammationAnti-TNF biologics
IL-1β2-6 hours6-8 hoursFever, acute phase responseIL-1 receptor antagonists
  • Cytokines: transcriptional regulation, sustained effects

    • TNF-α: peak at 1-4 hours, induces other cytokines
    • IL-1β: fever, acute phase proteins, >39°C within 2 hours
    • IL-6: hepatic acute phase response, CRP elevation
    • IL-10: anti-inflammatory, resolution promotion
  • Chemokines: directional cell recruitment

    • IL-8 (CXCL8): neutrophil chemotaxis, peak at 4-8 hours
    • MCP-1 (CCL2): monocyte recruitment, sustained elevation
    • Eotaxin (CCL11): eosinophil chemotaxis, allergic responses

⭐ Clinical Pearl: TNF-α levels >50 pg/mL predict severe inflammatory response with >85% sensitivity. Levels >200 pg/mL indicate systemic inflammatory response syndrome (SIRS) with shock risk >60%.

💡 Master This: COX-1 inhibition causes gastric ulcers (loss of protective PGE2), while COX-2 selective inhibition reduces inflammation without gastric toxicity but increases cardiovascular risk through PGI2 suppression.

The mediator cascade timing creates therapeutic windows where early intervention with specific inhibitors prevents amplification cascades that lead to tissue damage and chronic inflammation, connecting directly to how these molecular signals drive the vascular changes that create clinical signs.


🎯 Molecular Mediator Networks: The Chemical Command System

🌊 Vascular Response Patterns: The Hemodynamic Theater

The Vascular Response Architecture

  • Vasodilation Cascade (Peak: 5-15 minutes)

    • Arteriolar diameter: increases 2-4 fold within 5 minutes
    • Blood flow: increases 3-10 fold in affected tissues
    • Mediator hierarchy: histamine → PGE2 → nitric oxide
      • Histamine: immediate response, 30 seconds to 5 minutes
      • PGE2: sustained response, 15 minutes to 4 hours
      • Nitric oxide: endothelial-dependent, continuous production
      • Local temperature: increases 2-4°C above baseline
  • Permeability Changes (Peak: 15-30 minutes)

    • Endothelial gap formation: intercellular spaces increase 5-20 fold
    • Protein extravasation: albumin leakage increases 10-50 fold
    • Hydrostatic pressure: increases 15-25 mmHg in postcapillary venules
      • Normal capillary pressure: 25-35 mmHg
      • Inflammatory pressure: 40-60 mmHg
      • Filtration coefficient: increases 100-1000 fold
Loading diagram…

📌 Remember: FLOW describes vascular changes - Flow increases (vasodilation), Leakage increases (permeability), Oncotic pressure drops (protein loss), Water accumulates (edema formation).

Vascular ParameterNormal ValueInflammatory ChangeTime CourseClinical Sign
Arteriolar diameter20-50 μm↑ 2-4 fold5-15 minutesErythema, heat
Capillary pressure25-35 mmHg↑ to 40-60 mmHg15-30 minutesEdema formation
Permeability coefficientBaseline↑ 100-1000 fold15-60 minutesProtein extravasation
Blood flow velocity0.5-1.0 mm/sec↑ 3-10 fold initially5-30 minutesPulsatile erythema
Plasma protein concentration6-8 g/dL↓ 20-40% locally30-120 minutesTissue swelling
  • Flow velocity reduction: drops to 10-20% of normal
  • Hematocrit increase: local concentration rises 40-60%
  • Leukocyte margination: white cells line vessel walls
    • Normal flow: leukocytes in central stream
    • Inflammatory stasis: leukocytes along endothelium
    • Rolling velocity: decreases from 1000 to 5 μm/sec
  • Pressure Gradient Changes (Sustained: 2-24 hours)
    • Interstitial pressure: increases from -3 to +5 mmHg
    • Lymphatic drainage: increases 10-20 fold initially
    • Oncotic pressure gradient: reverses in severe inflammation
      • Normal gradient: plasma > interstitium by 15-20 mmHg
      • Inflammatory reversal: interstitium > plasma in severe cases

⭐ Clinical Pearl: Pitting edema indicates interstitial pressure >5 mmHg with protein concentration >3 g/dL. Non-pitting edema suggests lymphatic obstruction or high-protein exudate with >4 g/dL protein.

💡 Master This: Erythema that blanches indicates vasodilation without vessel damage, while non-blanching erythema suggests extravasated red blood cells or vessel wall necrosis requiring different therapeutic approaches.

Vascular response patterns create the foundation for understanding how cellular recruitment follows specific adhesion cascades that determine which cell types reach inflamed tissues and when therapeutic interventions can modify inflammatory outcomes.


🌊 Vascular Response Patterns: The Hemodynamic Theater

🎪 Cellular Recruitment Choreography: The Adhesion Cascade

The Recruitment Sequence Architecture

  • Step 1: Capture and Rolling (Velocity: 1000 → 50 μm/sec)
    • Selectin-mediated interactions: low-affinity, high-capacity binding
    • P-selectin: stored in Weibel-Palade bodies, mobilized in 5 minutes
    • E-selectin: transcriptionally induced, peaks at 4-6 hours
    • L-selectin: constitutively expressed on leukocytes
      • Rolling velocity: decreases 20-fold from free flow
      • Contact duration: increases from milliseconds to seconds
      • Shear stress threshold: effective at 1-10 dynes/cm²
Loading diagram…
  • Step 2: Activation and Firm Adhesion (Duration: 30-60 seconds)
    • Chemokine gradient recognition: G-protein coupled receptor activation
    • Integrin conformational change: low → high affinity transition
    • LFA-1 (CD11a/CD18): binds ICAM-1, universal leukocyte adhesion
    • Mac-1 (CD11b/CD18): neutrophil-specific, complement receptor
      • Integrin activation: occurs within 10-30 seconds
      • Adhesion strength: increases 1000-fold over selectin binding
      • Shear resistance: withstands >100 dynes/cm²

📌 Remember: SAIL describes the adhesion cascade - Selectin capture, Activation by chemokines, Integrin firm adhesion, Leukocyte transmigration. Each step requires specific molecular interactions with distinct therapeutic targets.

Adhesion StepKey MoleculesTime CourseVelocity ChangeTherapeutic Target
CaptureP/E/L-selectinSeconds1000 → 50 μm/secSelectin antagonists
RollingSelectin/ligandMinutes50 → 5 μm/secFucoidin, sialyl Lewis
ActivationChemokines/GPCR10-30 secondsDecelerationChemokine receptor blockers
Firm adhesionIntegrins/ICAM30-60 secondsComplete arrestAnti-integrin antibodies
TransmigrationPECAM-1, JAMs2-5 minutesTissue entryJunction modulators
  • Paracellular route: 95% of leukocytes use intercellular junctions
  • Transcellular route: 5% traverse through endothelial cell body
  • PECAM-1 (CD31): homophilic interactions guide junction passage
  • JAM proteins: junctional adhesion molecules, barrier regulation
    • Junction width: expands from 20 nm to 200-500 nm
    • Transmigration rate: 1-5 cells/minute per 100 μm vessel length
    • Basement membrane: **degraded by matrix metalloproteinases
  • Step 4: Tissue Migration (Velocity: 10-50 μm/minute)
    • Chemotactic gradient following: directional migration toward source
    • Integrin-mediated traction: β1 and β2 integrins bind matrix
    • Proteolytic path creation: MMPs clear tissue barriers
      • Migration speed: varies by cell type and tissue density
      • Neutrophils: fastest, 20-50 μm/minute
      • Monocytes: moderate, 10-30 μm/minute
      • Lymphocytes: slowest, 5-15 μm/minute

⭐ Clinical Pearl: LAD (Leukocyte Adhesion Deficiency) patients lack functional β2 integrins, causing recurrent bacterial infections with neutrophil counts >50,000/μL but no pus formation due to failed tissue recruitment.

💡 Master This: Selectin deficiency causes mild bleeding (platelet adhesion defects) and recurrent infections, while integrin deficiency causes severe immunodeficiency with life-threatening bacterial infections but normal platelet function.

The adhesion cascade precision enables targeted anti-inflammatory therapies that selectively block specific recruitment steps, connecting to how different inflammatory patterns create distinct clinical presentations requiring pattern-specific therapeutic approaches.


🎪 Cellular Recruitment Choreography: The Adhesion Cascade

🔄 Resolution and Repair Networks: The Healing Command Center

The Resolution Program Architecture

  • Active Resolution Initiation (Peak: 12-24 hours)
    • Lipoxin A4 (LXA4): "braking signal" for neutrophil recruitment
    • Resolvin E1 (RvE1): promotes neutrophil apoptosis and clearance
    • Protectin D1 (PD1): neuroprotective, anti-inflammatory
    • Maresin 1 (MaR1): macrophage-derived, tissue regeneration
      • LXA4 production: peaks at 12-24 hours after inflammation onset
      • Resolution index: LXA4:LTB4 ratio >1 indicates active resolution
      • Neutrophil apoptosis: increases 5-10 fold with resolution mediators
Loading diagram…
  • Efferocytosis Enhancement (Peak: 24-48 hours)
    • "Find-me" signals: ATP, UTP, fractalkine from apoptotic cells
    • "Eat-me" signals: phosphatidylserine exposure on apoptotic membranes
    • Macrophage reprogramming: M1 → M2 phenotype switch
    • Clearance capacity: each macrophage engulfs 5-20 apoptotic neutrophils
      • Efferocytosis efficiency: >95% in successful resolution
      • Failed clearance: <80% efficiency leads to secondary necrosis
      • Anti-inflammatory switch: occurs within 2-4 hours of efferocytosis

📌 Remember: CLEAR describes resolution mechanisms - Cessation of neutrophil recruitment, Lipoxin production, Efferocytosis activation, Anti-inflammatory cytokines, Repair program initiation.

Resolution PhaseKey MediatorsTime CourseCellular EventsFailure Consequence
InitiationLXA4, RvE112-24 hoursNeutrophil recruitment stopsPersistent neutrophilia
ClearancePS, MFG-E824-48 hoursApoptotic cell removalSecondary necrosis
RepairTGF-β, PDGF48-96 hoursTissue regeneration beginsChronic inflammation
RestorationIL-10, TGF-β3-7 daysNormal function returnsFibrosis, dysfunction
  • Growth factor release: PDGF, TGF-β, VEGF from activated macrophages
  • Angiogenesis initiation: new vessel formation within 72 hours
  • Fibroblast recruitment: collagen synthesis begins day 3-5
  • Epithelial regeneration: stem cell activation and proliferation
    • VEGF levels: increase 10-50 fold during repair phase
    • Collagen synthesis: peaks at 7-14 days post-injury
    • Tensile strength: reaches 80% of normal by 6-8 weeks
  • Resolution Biomarkers (Monitoring: Days to weeks)
    • Resolution indices: quantitative measures of healing progress
    • Neutrophil clearance: >90% reduction from peak levels
    • Pro-resolving mediator ratios: LXA4:LTB4 >1, RvE1:PGE2 >0.5
      • CRP normalization: <3 mg/L indicates systemic resolution
      • ESR return: <20 mm/hr suggests inflammatory resolution
      • Tissue function: >90% baseline indicates successful healing

⭐ Clinical Pearl: Resolution index <0.5 (pro-inflammatory:pro-resolving mediator ratio) predicts chronic inflammation development with >80% accuracy. Early intervention with omega-3 fatty acids can restore resolution capacity.

💡 Master This: Failed efferocytosis creates secondary necrosis with damage-associated molecular patterns (DAMPs) that perpetuate inflammation. Therapeutic enhancement of macrophage clearance prevents chronic inflammatory diseases.

Resolution network mastery enables predictive medicine where early resolution biomarkers guide therapeutic decisions to promote healing rather than simply suppress inflammation, creating the foundation for precision inflammatory medicine.


🔄 Resolution and Repair Networks: The Healing Command Center

🎯 Clinical Mastery Arsenal: Inflammatory Pattern Recognition

Essential Pattern Recognition Framework

  • Acute Inflammatory Signatures (0-72 hours)
    • Neutrophil predominance: >80% of inflammatory cells
    • Rapid onset: symptoms develop within 6-24 hours
    • High fever: >38.5°C with rigors
    • Elevated acute phase: CRP >100 mg/L, ESR >50 mm/hr
      • Bacterial pattern: Left shift, toxic granulation
      • Viral pattern: Lymphocyte predominance after 48 hours
      • Allergic pattern: Eosinophil count >10%
Loading diagram…

📌 Remember: RAPID identifies acute inflammation - Red, hot, swollen, Acute onset <24 hours, Pain prominent, Increased WBC >15,000, Dominant neutrophils >80%.

Pattern TypeOnsetDominant CellKey MarkersClinical Examples
Acute Bacterial<24 hoursNeutrophils >80%CRP >100 mg/LPneumonia, cellulitis
Acute Viral24-72 hoursLymphocytes >60%Normal CRPViral hepatitis, myocarditis
Chronic Active>2 weeksMixed cellularESR >50 mm/hrRheumatoid arthritis
GranulomatousWeeks-monthsEpithelioid cellsACE elevatedSarcoidosis, tuberculosis
AllergicMinutes-hoursEosinophils >10%IgE >1000 IU/mLAnaphylaxis, drug allergy
  • Macrophage/lymphocyte predominance: >70% of inflammatory cells
  • Tissue remodeling: fibrosis, angiogenesis, architectural changes
  • Systemic effects: weight loss, fatigue, anemia of chronic disease
  • Persistent elevation: ESR >30 mm/hr, CRP >10 mg/L
    • Autoimmune pattern: ANA positive, complement consumption
    • Granulomatous pattern: Epithelioid cells, giant cells
    • Neoplastic pattern: Atypical cells, monoclonal populations
  • Resolution Assessment Framework (Days to weeks)
    • Clinical improvement: symptom reduction >50% within 48-72 hours
    • Laboratory normalization: CRP reduction >50% within 5-7 days
    • Functional restoration: return to baseline activity within 1-2 weeks
      • Successful resolution: all parameters normalize
      • Incomplete resolution: persistent elevation of inflammatory markers
      • Failed resolution: progression to chronic inflammation

⭐ Clinical Pearl: CRP reduction <50% after 72 hours of appropriate therapy predicts treatment failure with >85% accuracy. Alternative diagnosis or resistant pathogen should be considered.

💡 Master This: Eosinophil count >1,500/μL with tissue infiltration indicates hypereosinophilic syndrome requiring immediate evaluation for cardiac involvement (occurs in 60% of cases) and potential organ damage.

Therapeutic Timing Optimization

  • Early Intervention Windows (0-6 hours)

    • Antihistamines: maximum efficacy within 30 minutes
    • Corticosteroids: genomic effects require 4-6 hours
    • NSAIDs: optimal timing at 1-4 hours when prostaglandin synthesis peaks
  • Resolution Enhancement (12-48 hours)

    • Omega-3 supplementation: promotes specialized pro-resolving mediators
    • Macrophage activation: enhances efferocytosis capacity
    • Antioxidant support: prevents resolution failure

This clinical mastery framework enables precision inflammatory medicine where pattern recognition drives targeted interventions that optimize healing outcomes while minimizing therapeutic complications and preventing chronic inflammatory disease development.

🎯 Clinical Mastery Arsenal: Inflammatory Pattern Recognition

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

All Lessons (10)

Practice Questions: Inflammation and Repair

  1. 1. A 25-year-old woman with Raynaud phenomenon cannot form a fist. Her hands are shown in the photograph. What is the most likely diagnosis?

    • A. En coup de sabre
    • B. Systemic sclerosis
    • C. Plaque morphea
    • D. Rheumatoid arthritis
    Show answer

    Answer: B. Systemic sclerosis

    Systemic sclerosis is supported by Raynaud phenomenon and the photographed sclerodactyly with flexion contractures, which explain impaired fist formation. En coup de sabre is localized linear morphea of the forehead or scalp rather than this hand pattern. Plaque morphea produces circumscribed indurated plaques rather than the characteristic digital changes shown. Rheumatoid arthritis can impair fist formation through synovitis or deformity, but it does not explain the photographed sclerodactyly.

  2. 2. First mediator of inflammation to be released is

    • A. PAF-acether
    • B. Histamine
    • C. Interleukin-1
    • D. Nitric oxide
    Show answer

    Answer: B. Histamine

    Histamine - Histamine is the first mediator released during many inflammatory and allergic responses, primarily from mast cells and basophils. - It produces early vasodilation and increased vascular permeability, causing the characteristic initial vascular changes of inflammation. PAF-acether - PAF-acether generally participates in the amplification of inflammation rather than being the earliest mediator released. - Its effects include platelet aggregation and actions on vascular smooth muscle, but histamine is the characteristic initial mediator. Nitric oxide - Nitric oxide contributes to vascular relaxation and inflammatory regulation, but it is not typically the first mediator released. - It has mainly regulatory vascular effects during inflammation, whereas histamine initiates early vasodilation and increased permeability. Interleukin-1 - Interleukin-1 is released after initial mediators such as histamine and therefore does not account for the earliest inflammatory response. - Produced mainly by activated macrophages, it promotes cytokine-mediated inflammation and contributes to later response amplification.

  3. 3. Which pair of findings is most characteristic of chronic inflammation?

    • A. Edema with neutrophilic infiltration
    • B. Fibrosis with lymphocytic infiltration
    • C. Microabscesses with neutrophilic infiltration
    • D. Hyperemia with vascular dilation
    Show answer

    Answer: B. Fibrosis with lymphocytic infiltration

    Fibrosis with lymphocytic infiltration - Lymphocyte infiltration is characteristic of chronic inflammation, in which lymphocytes, plasma cells, and macrophages persist at the site of injury. - Ongoing injury and repair promote tissue fibrosis, producing scarring and potentially causing tissue destruction and loss of organ function. Edema with neutrophilic infiltration - Edema primarily reflects increased vascular permeability, a prominent feature of acute inflammation rather than the defining cellular and tissue changes of chronic inflammation. - Neutrophilic infiltration accompanying edema favors acute inflammation rather than the fibrosis and mononuclear cell infiltration characteristic of chronic inflammation. Microabscesses with neutrophilic infiltration - Microabscesses are small localized collections of neutrophils and indicate suppurative inflammation rather than the characteristic pattern of chronic inflammation. - Chronic inflammation instead usually features lymphocytes, plasma cells, and macrophages, although neutrophils may occasionally coexist in ongoing or acute-on-chronic inflammation. Hyperemia with vascular dilation - Hyperemia results from vasodilation and is a classic feature of acute inflammation, contributing to redness and warmth at the affected site. - Some vascular changes can persist in chronic inflammation, but hyperemia with vascular dilation is not its defining characteristic.

  4. 4. Which of the following is NOT a characteristic feature of DiGeorge syndrome?

    • A. Hypocalcemic tetany
    • B. Eczematous dermatitis
    • C. T cell lymphopenia
    • D. Mucocutaneous candidiasis
    Show answer

    Answer: B. Eczematous dermatitis

    Eczematous dermatitis - Eczematous dermatitis is not a characteristic feature of DiGeorge syndrome, whose defining abnormalities include thymic and parathyroid hypoplasia. - Eczema is more typically associated with atopic disorders, Hyper-IgE syndrome, or Wiskott–Aldrich syndrome, making it the best answer. Hypocalcemic tetany - Hypocalcemic tetany is a recognized feature of DiGeorge syndrome because parathyroid hypoplasia causes hypocalcemia and increased neuromuscular excitability. - The resulting low serum calcium can produce muscle spasms, paresthesias, and tetany, so this option does not answer the question. Mucocutaneous candidiasis - Mucocutaneous candidiasis can occur in DiGeorge syndrome because T-cell deficiency impairs cellular immunity against fungal organisms. - Thymic hypoplasia causes impaired cell-mediated immunity, increasing susceptibility to Candida infections of the skin and mucous membranes. T cell lymphopenia - T-cell lymphopenia is characteristic of DiGeorge syndrome because thymic hypoplasia or aplasia disrupts T-cell maturation. - Reduced cellular immunity increases susceptibility to viral, fungal, and intracellular bacterial infections; B-cell numbers are usually preserved.

  5. 5. Neutrophil hypomotility syndrome is due to?

    • A. Defect in free radical production
    • B. Deficiency of leukocyte integrins
    • C. Defective actin polymerization
    • D. Absence of actin
    Show answer

    Answer: C. Defective actin polymerization

    Defective actin polymerization - Neutrophil movement requires actin polymerization at the leading edge to form lamellipodia and propel the cell forward. - In hypomotility, defective conversion of G-actin to F-actin impairs chemotaxis and random migration, while phagocytic and bactericidal functions may remain intact. Defect in free radical production - Free radical production is involved in the respiratory burst, not neutrophil movement; its defect characteristically causes chronic granulomatous disease. - This choice explains impaired microbial killing rather than hypomotility, because neutrophil migration depends primarily on cytoskeletal remodeling and chemotaxis. Absence of actin - Actin is an essential structural protein, so its complete absence would be incompatible with normal cell viability rather than causing an isolated motility defect. - The abnormality is defective actin assembly or polymerization, not total absence of the protein; dynamic filament remodeling is required for migration. Deficiency of leukocyte integrins - Leukocyte integrin deficiency causes leukocyte adhesion deficiency type 1, impairing firm endothelial adhesion through defective CD18-containing β2-integrins. - LAD typically causes marked leukocytosis and absent pus formation, distinguishing defective adhesion from the impaired cytoskeletal movement of hypomotility syndrome.

  6. 6. Which cytokine activates the given cell?

    • A. Interleukin-5 (IL-5)
    • B. Interleukin-1 (IL-1)
    • C. Interleukin-6 (IL-6)
    • D. Interleukin-2 (IL-2)
    Show answer

    Answer: A. Interleukin-5 (IL-5)

    Interleukin-5 (IL-5) - Interleukin-5 (IL-5) is the principal cytokine promoting eosinophil differentiation, activation, and survival from bone marrow precursors. - It also enhances eosinophil recruitment and degranulation, making it the best match for the depicted cell. Interleukin-2 (IL-2) - Interleukin-2 (IL-2) primarily promotes T-lymphocyte proliferation and activation as a growth factor in adaptive immunity. - It has minimal direct effect on eosinophil function, so it does not best explain activation of the depicted cell. Interleukin-1 (IL-1) - Interleukin-1 (IL-1) activates macrophages and endothelial cells and contributes to fever and the acute inflammatory response. - Although pro-inflammatory, it does not specifically drive eosinophil activation, which distinguishes it from IL-5. Interleukin-6 (IL-6) - Interleukin-6 (IL-6) promotes B-cell differentiation and hepatic acute-phase protein synthesis during inflammation. - It may have broader inflammatory effects but does not specifically activate eosinophils as effectively as IL-5.

  7. 7. Which of the following is NOT a property of molecular chaperones?

    • A. Cause folding of proteins
    • B. Are lipid in nature
    • C. Include heat shock proteins
    • D. May have ATPase activity
    Show answer

    Answer: B. Are lipid in nature

    Are lipid in nature - Chaperones are proteins, including heat shock proteins and chaperonins, rather than lipid molecules composed of fatty acids. - Their role is to assist protein folding and prevent aggregation; therefore, being lipid in nature is the false statement. Cause folding of proteins - Chaperones assist protein folding by binding nascent or partially unfolded proteins and guiding them toward their correct three-dimensional structure. - Although they do not independently determine every folding event, this option broadly describes their folding-assistance function and is not the false statement. Include heat shock proteins - Several chaperone families are heat shock proteins, including Hsp70, Hsp90, and Hsp60/chaperonins. - These proteins are commonly increased during cellular stress, where they help refold damaged proteins and limit aggregation. May have ATPase activity - Many chaperones, including Hsp70 and GroEL/GroES, use ATP hydrolysis during their functional cycle. - ATPase activity drives conformational changes involved in client-protein binding, release, and refolding, so this statement is valid.

  8. 8. Which of the following statements about wound healing is NOT correct?

    • A. Diabetes mellitus delays wound closure
    • B. Hematomas improve tissue apposition
    • C. Foreign bodies cause persistent inflammation
    • D. Infection causes tissue destruction
    Show answer

    Answer: B. Hematomas improve tissue apposition

    Hematomas improve tissue apposition - Hematomas do not promote healing; they can support bacterial growth, increase tissue tension, and compromise oxygen delivery at the wound site. - This is the false statement because blood collections interfere with tissue apposition and the local conditions required for effective wound repair. Diabetes mellitus delays wound closure - Diabetes mellitus, particularly with poor glycemic control, impairs immune function, blood flow, and tissue repair mechanisms, thereby delaying wound closure. - This is a true statement, not the false choice: diabetic wounds have increased susceptibility to infection and commonly demonstrate delayed healing. Infection causes tissue destruction - Infection prolongs inflammation, causes tissue destruction, and increases metabolic demands, all of which delay the normal sequence of wound repair. - This is a true statement because bacterial injury and toxin production impair granulation tissue formation and epithelialization. Foreign bodies cause persistent inflammation - A retained foreign body produces persistent inflammation and can increase the risk of chronic infection, preventing orderly progression through wound-healing phases. - This is a true statement, as ongoing foreign-body irritation interferes with tissue repair rather than supporting healing.

  9. 9. After repeated pairing of a bell with food, a dog salivates when the bell is presented alone. This salivation is an example of which type of response?

    • A. Unconditioned response
    • B. Operant response
    • C. Orienting response
    • D. Conditioned response
    Show answer

    Answer: D. Conditioned response

    Conditioned response is correct because bell–food pairing makes the previously neutral bell elicit salivation. Unconditioned response describes salivation to food without prior learning. Operant response is shaped by its consequences rather than elicited through this stimulus pairing. Orienting response directs attention toward a stimulus rather than constituting the acquired salivary response described here.

  10. 10. Which of the following is NOT an action or characteristic of interleukin-1?

    • A. Predominant production by monocytes/macrophages
    • B. Endogenous pyrogen activity
    • C. Inhibition of T-cell IL-2 production
    • D. Stimulation of hepatic synthesis of acute-phase proteins
    Show answer

    Answer: C. Inhibition of T-cell IL-2 production

    Inhibition of T-cell IL-2 production - IL-1 enhances, rather than inhibits, IL-2 production by T-cells, supporting T-cell proliferation and immune activation. - Therefore, this statement is false; IL-1 can act synergistically with IL-6 and TNF-α during inflammation, while IL-2 promotes T-cell responses. Stimulation of hepatic synthesis of acute-phase proteins - IL-1 promotes acute-phase protein synthesis by stimulating hepatocytes during systemic inflammation. - This is a true statement; hepatic production of proteins such as C-reactive protein and serum amyloid A contributes to innate host defense. Predominant production by monocytes/macrophages - Monocytes and macrophages are the primary sources of IL-1α and IL-1β after activation by inflammatory stimuli. - Although neutrophils, dendritic cells, and endothelial cells may also produce IL-1, the monocyte-macrophage system remains the predominant source, making this statement true. Endogenous pyrogen activity - IL-1 is an endogenous pyrogen that acts on the hypothalamus to produce fever during the acute-phase response. - It induces hypothalamic prostaglandin synthesis, raising the thermoregulatory set point; therefore, this statement is true.

Flashcards: Inflammation and Repair

  1. 1. Acute inflammation arises in response to _____ or _____

    Show answer

    infection · tissue necrosis

  2. 2. Fever in inflammation is mediated by release of _____, _____ and _____ by _____ in response to pyrogens (e.g. LPS from bacteria)

    Show answer

    IL-1 · TNF · IL-6 · macrophages

  3. 3. _____ and _____ are cellular adhesion molecules that are upregulated on endothelium during leukocyte adhesion

    Show answer

    ICAM-1 · VCAM-1

  4. 4. The most common mechanism of vascular leakage in acute inflammation is the of endothelial cells

    Show answer

    contraction

  5. 5. In the setting of chronic inflammation, macrophages can be activated to M1 macrophages by stimulation from _____ cells, resulting in a _____ phenotype

    Show answer

    Th1 · proinflammatory

  6. 6. Swelling in inflammation is mediated by endothelial cell disruption (due to tissue damage) and endothelial cell contraction (caused by _____, _____, and _____)

    Show answer

    leukotrienes · histamine · serotonin

  7. 7. In the setting of chronic inflammation, macrophages can be activated to M2 macrophages by stimulation from _____ cells, resulting in a _____ phenotype

    Show answer

    Th2 · antiinflammatory

  8. 8. The histopathological section has giant cells with a central ring of nuclei suggestive of _____

    Show answer

    Xanthoma

  9. 9. What type of cells are the following examples? _____ ,smooth muscle cells

    Show answer

    Stable (Quiescent)

  10. 10. Acute inflammation typically results in resolution and healing, which is mediated by _____ and _____

    Show answer

    IL-10 · TGF-B

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF